The recombinant tissue plasminogen activator (rTPA) enhances Il-8 and matrix metalalloproteinase 1 activities
The rtPA has been used extensively for cardiovascular disease to lyse preformed clots. However the dosage used (100mg) for the treatment of the myocardial infarction results cerebrovascular accidents in 9% of patients treated. The tPA therapy with much lower dosage (3 mg bid) dose for 2 weeks durati...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2004-02, Vol.113 (2), p.S214-S215 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S215 |
---|---|
container_issue | 2 |
container_start_page | S214 |
container_title | Journal of allergy and clinical immunology |
container_volume | 113 |
creator | Hill, B.D. Nair, U. Kanangat, S. Mora, R. Barbieri, M. Yoo, T.J. |
description | The rtPA has been used extensively for cardiovascular disease to lyse preformed clots. However the dosage used (100mg) for the treatment of the myocardial infarction results cerebrovascular accidents in 9% of patients treated. The tPA therapy with much lower dosage (3 mg bid) dose for 2 weeks duration was found to be effective in restoring hearing in certain hearing loss patients. (R. Mora et al Annals Oto Rhino Laryn, in press). The specific aim of this study is to examine the effect of tPA on inflammatory cascades.
We have added Actlyse (rtPA) in graded concentration to 80% confluent monolayers of A549 (human lung epithelial cells – obtained from ATCC) in a 24 well plate. They were then incubated at 37°C (5% C0
2). The cells were harvested after 24 hours. Total RNA was isolated and reversed transcribed using oligo dT and AMV Reverse Transcriptase. The CDNAs for house keeping gene GAPDH, Chemokines, MMP-1 (matrix collagen degrading enzymes) were amplified IL-1α, IL-6, cxc chemokine IL-8 (a potent angiogenic factor and neutrophil chemattractant).
We observed a significant increase in steady state mRNA level of IL-8 and mmp-1 in tPA treated human lung epithelial cell line, in a concentration dependent manner.
These results indicate that the pathophysiologic effects pf tPA are mediated through regulating inflammatory cascade. |
doi_str_mv | 10.1016/j.jaci.2004.01.221 |
format | Article |
fullrecord | <record><control><sourceid>proquest_elsev</sourceid><recordid>TN_cdi_proquest_journals_1504873294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674904002222</els_id><sourcerecordid>3239843331</sourcerecordid><originalsourceid>FETCH-LOGICAL-e814-f3281905e420a32738a0e104106eb4f3ed1bcf5e75b3f2ec600aa91aca69b94f3</originalsourceid><addsrcrecordid>eNotkEtLA0EQhAdRMEb_gKcBL3rYtXv2OeAlBB-BgB5yH3o3vWaWfcSdSfDnOyGemobq6qpPiHuEGAHz5zZuqbaxAkhjwFgpvBAzBF1EeamySzED0BjlRaqvxY1zLYQ9KfVM9Jsdy4nrsa_sQIOX3jp3YLnvyPV2GL95kFR7eyQ_TvJx2nwtniQPOxpqdnLVRaWkYSt78pP9lT176qjrxv00eg6GjiWe76237G7FVUOd47v_ORebt9fN8iNaf76vlot1xCWmUZOoEjVknCqgRBVJScAIKULOVdokvMWqbjIusippFNc5AJFGqinXlQ6CuXg424YYPwd23rTjYRrCR4MZpGWRKJ0G1ctZxSHJ0fJkXG059NraAMSb7WgNgjnxNa058TUnvgbQBL7JHyemcLo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504873294</pqid></control><display><type>article</type><title>The recombinant tissue plasminogen activator (rTPA) enhances Il-8 and matrix metalalloproteinase 1 activities</title><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hill, B.D. ; Nair, U. ; Kanangat, S. ; Mora, R. ; Barbieri, M. ; Yoo, T.J.</creator><creatorcontrib>Hill, B.D. ; Nair, U. ; Kanangat, S. ; Mora, R. ; Barbieri, M. ; Yoo, T.J.</creatorcontrib><description>The rtPA has been used extensively for cardiovascular disease to lyse preformed clots. However the dosage used (100mg) for the treatment of the myocardial infarction results cerebrovascular accidents in 9% of patients treated. The tPA therapy with much lower dosage (3 mg bid) dose for 2 weeks duration was found to be effective in restoring hearing in certain hearing loss patients. (R. Mora et al Annals Oto Rhino Laryn, in press). The specific aim of this study is to examine the effect of tPA on inflammatory cascades.
We have added Actlyse (rtPA) in graded concentration to 80% confluent monolayers of A549 (human lung epithelial cells – obtained from ATCC) in a 24 well plate. They were then incubated at 37°C (5% C0
2). The cells were harvested after 24 hours. Total RNA was isolated and reversed transcribed using oligo dT and AMV Reverse Transcriptase. The CDNAs for house keeping gene GAPDH, Chemokines, MMP-1 (matrix collagen degrading enzymes) were amplified IL-1α, IL-6, cxc chemokine IL-8 (a potent angiogenic factor and neutrophil chemattractant).
We observed a significant increase in steady state mRNA level of IL-8 and mmp-1 in tPA treated human lung epithelial cell line, in a concentration dependent manner.
These results indicate that the pathophysiologic effects pf tPA are mediated through regulating inflammatory cascade.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2004.01.221</identifier><language>eng</language><publisher>St. Louis: Mosby, Inc</publisher><ispartof>Journal of allergy and clinical immunology, 2004-02, Vol.113 (2), p.S214-S215</ispartof><rights>2004</rights><rights>Copyright Elsevier Limited Feb 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2004.01.221$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Hill, B.D.</creatorcontrib><creatorcontrib>Nair, U.</creatorcontrib><creatorcontrib>Kanangat, S.</creatorcontrib><creatorcontrib>Mora, R.</creatorcontrib><creatorcontrib>Barbieri, M.</creatorcontrib><creatorcontrib>Yoo, T.J.</creatorcontrib><title>The recombinant tissue plasminogen activator (rTPA) enhances Il-8 and matrix metalalloproteinase 1 activities</title><title>Journal of allergy and clinical immunology</title><description>The rtPA has been used extensively for cardiovascular disease to lyse preformed clots. However the dosage used (100mg) for the treatment of the myocardial infarction results cerebrovascular accidents in 9% of patients treated. The tPA therapy with much lower dosage (3 mg bid) dose for 2 weeks duration was found to be effective in restoring hearing in certain hearing loss patients. (R. Mora et al Annals Oto Rhino Laryn, in press). The specific aim of this study is to examine the effect of tPA on inflammatory cascades.
We have added Actlyse (rtPA) in graded concentration to 80% confluent monolayers of A549 (human lung epithelial cells – obtained from ATCC) in a 24 well plate. They were then incubated at 37°C (5% C0
2). The cells were harvested after 24 hours. Total RNA was isolated and reversed transcribed using oligo dT and AMV Reverse Transcriptase. The CDNAs for house keeping gene GAPDH, Chemokines, MMP-1 (matrix collagen degrading enzymes) were amplified IL-1α, IL-6, cxc chemokine IL-8 (a potent angiogenic factor and neutrophil chemattractant).
We observed a significant increase in steady state mRNA level of IL-8 and mmp-1 in tPA treated human lung epithelial cell line, in a concentration dependent manner.
These results indicate that the pathophysiologic effects pf tPA are mediated through regulating inflammatory cascade.</description><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNotkEtLA0EQhAdRMEb_gKcBL3rYtXv2OeAlBB-BgB5yH3o3vWaWfcSdSfDnOyGemobq6qpPiHuEGAHz5zZuqbaxAkhjwFgpvBAzBF1EeamySzED0BjlRaqvxY1zLYQ9KfVM9Jsdy4nrsa_sQIOX3jp3YLnvyPV2GL95kFR7eyQ_TvJx2nwtniQPOxpqdnLVRaWkYSt78pP9lT176qjrxv00eg6GjiWe76237G7FVUOd47v_ORebt9fN8iNaf76vlot1xCWmUZOoEjVknCqgRBVJScAIKULOVdokvMWqbjIusippFNc5AJFGqinXlQ6CuXg424YYPwd23rTjYRrCR4MZpGWRKJ0G1ctZxSHJ0fJkXG059NraAMSb7WgNgjnxNa058TUnvgbQBL7JHyemcLo</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Hill, B.D.</creator><creator>Nair, U.</creator><creator>Kanangat, S.</creator><creator>Mora, R.</creator><creator>Barbieri, M.</creator><creator>Yoo, T.J.</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20040201</creationdate><title>The recombinant tissue plasminogen activator (rTPA) enhances Il-8 and matrix metalalloproteinase 1 activities</title><author>Hill, B.D. ; Nair, U. ; Kanangat, S. ; Mora, R. ; Barbieri, M. ; Yoo, T.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e814-f3281905e420a32738a0e104106eb4f3ed1bcf5e75b3f2ec600aa91aca69b94f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hill, B.D.</creatorcontrib><creatorcontrib>Nair, U.</creatorcontrib><creatorcontrib>Kanangat, S.</creatorcontrib><creatorcontrib>Mora, R.</creatorcontrib><creatorcontrib>Barbieri, M.</creatorcontrib><creatorcontrib>Yoo, T.J.</creatorcontrib><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hill, B.D.</au><au>Nair, U.</au><au>Kanangat, S.</au><au>Mora, R.</au><au>Barbieri, M.</au><au>Yoo, T.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The recombinant tissue plasminogen activator (rTPA) enhances Il-8 and matrix metalalloproteinase 1 activities</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><date>2004-02-01</date><risdate>2004</risdate><volume>113</volume><issue>2</issue><spage>S214</spage><epage>S215</epage><pages>S214-S215</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>The rtPA has been used extensively for cardiovascular disease to lyse preformed clots. However the dosage used (100mg) for the treatment of the myocardial infarction results cerebrovascular accidents in 9% of patients treated. The tPA therapy with much lower dosage (3 mg bid) dose for 2 weeks duration was found to be effective in restoring hearing in certain hearing loss patients. (R. Mora et al Annals Oto Rhino Laryn, in press). The specific aim of this study is to examine the effect of tPA on inflammatory cascades.
We have added Actlyse (rtPA) in graded concentration to 80% confluent monolayers of A549 (human lung epithelial cells – obtained from ATCC) in a 24 well plate. They were then incubated at 37°C (5% C0
2). The cells were harvested after 24 hours. Total RNA was isolated and reversed transcribed using oligo dT and AMV Reverse Transcriptase. The CDNAs for house keeping gene GAPDH, Chemokines, MMP-1 (matrix collagen degrading enzymes) were amplified IL-1α, IL-6, cxc chemokine IL-8 (a potent angiogenic factor and neutrophil chemattractant).
We observed a significant increase in steady state mRNA level of IL-8 and mmp-1 in tPA treated human lung epithelial cell line, in a concentration dependent manner.
These results indicate that the pathophysiologic effects pf tPA are mediated through regulating inflammatory cascade.</abstract><cop>St. Louis</cop><pub>Mosby, Inc</pub><doi>10.1016/j.jaci.2004.01.221</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-6749 |
ispartof | Journal of allergy and clinical immunology, 2004-02, Vol.113 (2), p.S214-S215 |
issn | 0091-6749 1097-6825 |
language | eng |
recordid | cdi_proquest_journals_1504873294 |
source | Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
title | The recombinant tissue plasminogen activator (rTPA) enhances Il-8 and matrix metalalloproteinase 1 activities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_elsev&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20recombinant%20tissue%20plasminogen%20activator%20(rTPA)%20enhances%20Il-8%20and%20matrix%20metalalloproteinase%201%20activities&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Hill,%20B.D.&rft.date=2004-02-01&rft.volume=113&rft.issue=2&rft.spage=S214&rft.epage=S215&rft.pages=S214-S215&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2004.01.221&rft_dat=%3Cproquest_elsev%3E3239843331%3C/proquest_elsev%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504873294&rft_id=info:pmid/&rft_els_id=S0091674904002222&rfr_iscdi=true |